MiMedx Group, Inc.
Summary of Case:
NEW YORK - Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, announces the commencement of an investigation into MiMedx Group, Inc. (MDXG) ("MiMedx"). If you are a MiMedx shareholder, you are encouraged to contact Scott+Scott at (800) 404-7770 or email firstname.lastname@example.org to discuss your legal rights.
MiMedx develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues, and human skin and bone.
On December 15, 2016, a complaint was filed in the District of Minnesota (the "Whistleblower Complaint") that alleges that since at least 2014, MiMedx has engaged in a scheme of "channel stuffing," which MiMedx used to fraudulently recognize revenue in its certified financial statements before the revenue had been realized or realizable and earned.
What You Can Do
If you are a MiMedx shareholder and you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Michael Burnett at (800) 404-7770, or at email@example.com.
About Scott+Scott, Attorneys at Law, LLP
Scott+Scott have significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide.
Scott+Scott, Attorneys at Law, LLP
If you purchased this company's shares during the Class Period and suffered a loss or for further information about the case, please review the links below.